Suppr超能文献

白术内酯苷的线粒体能量调节作用通过激活自噬抑制肝细胞脂肪变性。

Mitochondrial Energy-Regulating Effect of Atractyloside Inhibits Hepatocellular Steatosis Through the Activation of Autophagy.

作者信息

Zhang Pengfei, Li Lijun, Sun Huimin, Zhang Yipeng, Zhang Guoliang, Zhang Tianyu, Zeng Changchun

机构信息

Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, China.

State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.

出版信息

Front Pharmacol. 2020 Sep 30;11:575695. doi: 10.3389/fphar.2020.575695. eCollection 2020.

Abstract

BACKGROUND AND AIM

Atractyloside (ATR), a mitochondrial uncoupler, is known for its specific inhibition of mitochondrial oxidative phosphorylation. Previous studies have reported that moderate mitochondrial uncoupling effect is beneficial to increase the decomposition and clearance of hepatic lipid, prevent the occurrence of fatty liver diseases. Moreover, the beneficial effects of mitochondrial uncouplers on type 2 diabetes and metabolic syndromes have been consistently observed. The present study investigated the effect of ATR on steatosis level of HepG2 cells treated with free fatty acid (FFA).

METHODS

Intracellular triglyceride level and Oil Red O staining were assessed, the mitochondrial adaptation and ADP/ATP ratio were analyzed, the protein level of AMPK, mTOR and LC3B, autophagic flux, and the co-localization of LC3B with lipid droplets was performed.

RESULTS

ATR treatment inhibited the activity of mitochondrial respiratory chain complexes I and IV, decreased the mitochondrial membrane potential, and increased the ADP/ATP ratio in the FFA-treated cells. Furthermore, ATR increased the gene expression and protein level of LC3B and promoted the autophagic flux processing from early autophagosome to late autolysosome by increasing the protein level of AMPKα and decreasing the protein level of mTOR. An increased number of autophagosomes (LC3B) was also observed in the lipid droplets. ATR treatment accelerated lipid degradation in the FFA-treated cells, and the lowest lipid content was observed in the cell group with 7.5 μM ATR.

CONCLUSION

Low concentrations (2.5, 5, and 7.5 μM) of ATR treatment could activate autophagy to accelerate the degradation of TGs in steatosis HepG2 cells; the mechanism may be related to the activation of the AMPK/mTOR pathway induced by the increased ADP/ATP ratio. In addition, the ideal concentration of ATR for improving steatotic HepG2 cells was 7.5 μM.

摘要

背景与目的

阿特拉津(ATR)是一种线粒体解偶联剂,以其对线粒体氧化磷酸化的特异性抑制作用而闻名。先前的研究报道,适度的线粒体解偶联效应有利于增加肝脏脂质的分解和清除,预防脂肪肝疾病的发生。此外,线粒体解偶联剂对2型糖尿病和代谢综合征的有益作用也一直被观察到。本研究探讨了ATR对游离脂肪酸(FFA)处理的HepG2细胞脂肪变性水平的影响。

方法

评估细胞内甘油三酯水平和油红O染色,分析线粒体适应性和ADP/ATP比值,检测AMPK、mTOR和LC3B的蛋白水平、自噬通量以及LC3B与脂滴的共定位。

结果

ATR处理抑制了FFA处理细胞中线粒体呼吸链复合物I和IV的活性降低了线粒体膜电位,并增加了ADP/ATP比值。此外,ATR增加了LC3B的基因表达和蛋白水平,并通过增加AMPKα的蛋白水平和降低mTOR的蛋白水平促进了自噬通量从早期自噬体到晚期自溶酶体的过程。在脂滴中也观察到自噬体(LC3B)数量增加。ATR处理加速了FFA处理细胞中的脂质降解,在7.5μM ATR的细胞组中观察到最低的脂质含量。

结论

低浓度(2.5、5和7.5μM)的ATR处理可激活自噬,加速脂肪变性HepG2细胞中甘油三酯的降解;其机制可能与ADP/ATP比值增加诱导的AMPK/mTOR途径激活有关。此外,改善脂肪变性HepG2细胞的理想ATR浓度为7.5μM。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd2/7556285/fd4d80e4a3ae/fphar-11-575695-g007.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验